EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Ceribell Inc.
- Study ID
- NCT07485244
- Status
- Recruiting
Conditions
- Delirium in the Intensive Care Unit
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ceribell EEG System — DEVICEEEG will be recorded with the Ceribell EEG System, including headband and recorder.
Study Details
The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
Key Dates
- Start date
- Apr 16, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Prospective Ceribell Delirium MonitoringEnrolled patients will undergo EEG monitoring with the Ceribell EEG System twice daily for up to 7 days.
Primary Outcome Measure
Prevalence of EEG Abnormalities on the Ceribell EEG System [ Time Frame: Starting baseline through study completion, up to 1 year. ]
Central Contacts
- Michelle Hofmann, MSN908-892-1193
- Alexandra C. Fietsam, PhD5632091704
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Wesley Ely, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Nashville, TN
By research site
Related Studies
- Ceribell Delirium Monitor Outcomes Pilot StudyNot Yet Recruiting · Ceribell Inc. · Irvine, California
- Phenobarbital for Agitated DeliriumPHASE3 · Not Yet Recruiting · Duke University · Durham, North Carolina